338 related articles for article (PubMed ID: 11923116)
21. Mucosal vaccine design and delivery.
Woodrow KA; Bennett KM; Lo DD
Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
[TBL] [Abstract][Full Text] [Related]
22. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
23. Mucosal adjuvants.
Harandi AM; Medaglini D
Curr HIV Res; 2010 Jun; 8(4):330-5. PubMed ID: 20353395
[TBL] [Abstract][Full Text] [Related]
24. New advances in mucosal vaccination.
Ranasinghe C
Immunol Lett; 2014 Oct; 161(2):204-6. PubMed ID: 24462961
[TBL] [Abstract][Full Text] [Related]
25. [Mucosal viral vaccines: progress and problems].
Gendon IuZ
Vopr Virusol; 2003; 48(4):4-10. PubMed ID: 12945199
[TBL] [Abstract][Full Text] [Related]
26. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
[TBL] [Abstract][Full Text] [Related]
27. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
28. Nanocarriers: a versatile approach for mucosal vaccine delivery.
Mody N; Sharma R; Agrawal U; Vyas SP
Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
[TBL] [Abstract][Full Text] [Related]
29. CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.
Christensen D; Foged C; Rosenkrands I; Lundberg CV; Andersen P; Agger EM; Nielsen HM
Int J Pharm; 2010 May; 390(1):19-24. PubMed ID: 19879346
[TBL] [Abstract][Full Text] [Related]
30. All things mucosal.
Thanavala Y; Lavelle E; Ogra P
Expert Rev Vaccines; 2009 Feb; 8(2):139-42. PubMed ID: 19196192
[TBL] [Abstract][Full Text] [Related]
31. Nanocarriers for systemic and mucosal vaccine delivery.
Shahiwala A; Vyas TK; Amiji MM
Recent Pat Drug Deliv Formul; 2007; 1(1):1-9. PubMed ID: 19075870
[TBL] [Abstract][Full Text] [Related]
32. Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens.
Gosselin EJ; Bitsaktsis C; Li Y; Iglesias BV
Arch Immunol Ther Exp (Warsz); 2009; 57(5):311-23. PubMed ID: 19688186
[TBL] [Abstract][Full Text] [Related]
33. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
Wu H; Bao Y; Wang X; Zhou D; Wu W
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
[TBL] [Abstract][Full Text] [Related]
34. Nanotechnology solutions for mucosal immunization.
Chadwick S; Kriegel C; Amiji M
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
[TBL] [Abstract][Full Text] [Related]
35. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
36. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
37. New strategies for using mucosal vaccination to achieve more effective immunization.
Walker RI
Vaccine; 1994 Apr; 12(5):387-400. PubMed ID: 8023545
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immunisation: adjuvants and delivery systems.
Moyle PM; McGeary RP; Blanchfield JT; Toth I
Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
[TBL] [Abstract][Full Text] [Related]
39. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
40. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Boyaka PN
J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
